Tdspharm Co., Ltd. (KOSDAQ:464280)

Market Cap	56.02B -24.9%
Revenue (ttm)	24.56B -20.3%
Net Income	3.28B -29.6%
EPS	620.38 -41.8%
Shares Out	5.53M
PE Ratio	16.33
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,128
Average Volume	27,138
Open	10,160.00
Previous Close	10,130.00
Day's Range	9,890.00 - 10,340.00
52-Week Range	8,330.00 - 14,250.00
Beta	n/a
RSI	58.41
Earnings Date	n/a

About Tdspharm

Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464280

Financial Performance

In 2024, Tdspharm's revenue was 27.52 billion, a decrease of -8.42% compared to the previous year's 30.05 billion. Earnings were 3.72 billion, a decrease of -20.69%.